BridgeMD
New treatment option for Metabolic Dysfunction-associated Steatotic Liver Disease
Official title Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
ClinicalTrials.gov ID: NCT06619808
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if hyperbaric oxygen therapy (HBOT) works to treat Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD). The main questions it aims to answer are: Does HBOT decreases the fat content and fibrosis state of liver in adult MASLD patients?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Metabolic dysfunction-associated steatotic liver disease patients
You likely can't join if
- Participants are unfit for hyperbaric treatment.
- Participants with prior oxygen therapy within the last 6 months.
- Participants with history of viral hepatitis, hemochromatosis, Wilson disease, autoimmune hepatitis, primary biliary cirrhosis, sclerosing...
- Participants with severe organ dysfunctions or malignant tumors.
- Participants have weight loss plan or major operations within the last 6 months.
- Participants are unable to provide informed consent or currently participating in or has within the last 3 months participated in any other clinical...
See the full eligibility criteria
- Metabolic dysfunction-associated steatotic liver disease patients
- Participants are unfit for hyperbaric treatment.
- Participants with prior oxygen therapy within the last 6 months.
- Participants with history of viral hepatitis, hemochromatosis, Wilson disease, autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, biliary obstruction, alpha-1 antitrypsin deficiency.
- Participants with severe organ dysfunctions or malignant tumors.
- Participants have weight loss plan or major operations within the last 6 months.
- Participants are unable to provide informed consent or currently participating in or has within the last 3 months participated in any other clinical trial.
- Participants are pregnant or lactating.
- Participants with claustrophobia or that cannot decompress properly.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.